Ron Davis Gets Standing Ovation

Ron Davis Gets Standing Ovation!
Very rare for a scientific presentation!
August 12 was an amazing day at OMF’s Community Symposium on the Molecular Basis of ME/CFS at Stanford University. The room was buzzing with positive energy. The researchers’ presentations were incredible and showed great insights into this disease. There were renowned scientists from all over the world, and from related fields revealing interesting new insights into ME/CFS research. Patients, caregivers, clinicians, and other researchers attending interacted with these scientists during breaks, lunch and an evening reception, and there was so much excitement and optimism in the room.
Here are some of the highlights from this amazing meeting (stay tuned for more!):
  • Additional comprehensive evidence that ME/CFS is a molecular disease was presented.(Yet another nail in the PACE coffin!)
  • Experts in metabolism, immunology, genomics, neurophysiology, electrical engineering and bioinformatics presented data.
  • We learned about innovative ways to find new pain drugs and saw elegant evidence of a clear connection between the immune system and the brain.
  • The scientists decided to continue as a “Working Group”, and are already planning multiple new ways to work together to facilitate and accelerate progress.
  • Nobel laureate Mario Capecchi noted how important patient participation is in studying any disease, and how impressed he was with the amount of ME/CFS patient participation!
  • In Ron Davis’ concluding remarks he stated that it is clear that what is missing is funding. He described ME/CFS as “a horribly underfunded disease”. Progress has been impressive despite the limited resources, but it is clear that more funding is needed to unravel this mystery and find treatments and a cure fast.
We need your help to accelerate the pace!
Every Donation of Every Size Brings Us Closer to A Cure.
 
Your past support has helped us to come this far, and now we need your help to expand our research efforts to the next level.
To End ME/CFS, the world is counting on brilliant researchers working collaboratively.
If you have ever thought to donate to our End ME/CFS project, NOW IS THE TIME! We need to keep the momentum going and leverage the expanding interest in finding a cure.
Sincerely,
 
Linda Tannenbaum
CEO/President
PS – Please forward this message to family and friends. Encourage them to join you in your support of OMF’s research for treatments and a cure.
Facebook
Twitter
WhatsApp
Email

Latest News

a multi-water colored image with the words, Severe ME Artists Project 2024 in white font outlined in black. the meaction action logo in the bottom right hand corner.

Severe ME Artists Project 2024

Quick Overview: Submit one piece of artwork – image, writing, or video Label your artwork with your name as you want it to appear, an underscore, and the number of years with severe ME Example: Lastname_FirstName_14 FirstNameOnly_ No copyrighted material If you are submitting a video, it must be under two minutes. Submission due by

Read More »
Light blue square with rainbows in the top left and bottom right corner. In the middle are the words, -Pride is Valid- No Matter How One Celebrates or Experiences It. #MEAction Board Member, Jennifer England, shares her views on Pride. The #MEAction logo in the top right corner.

Pride Is Valid No Matter How One Celebrates or Experiences It

In honor of Pride Month, #MEAction is sharing a heartfelt message from our board member, Jennifer England, about what Pride means to her and her wife who lives with severe ME. My wife and I have both been queer our whole lives, but in the 70s that was the quiet part you didn’t say out

Read More »

Questions to Ask Prospective MPs About ME/CFS

In the next few weeks, candidates will be knocking on doors seeking votes for the upcoming UK Election. It’s important that candidates from all parties are made aware of the challenges facing people with ME and Long Covid. It can be a little daunting to be unprepared so here are some questions you might want

Read More »
Scroll to Top